Technology | Cardiovascular Ultrasound | August 22, 2018

Philips Launches Epiq CVx and CVxi Cardiovascular Ultrasound Systems

Epiq CVx line offers cardiologists tailored applications for diagnostic, pediatric and interventional echocardiography with faster data processing, sharper imaging, robust automated quantification and customizable exam tools

Philips Launches Epiq CVx and CVxi Cardiovascular Ultrasound Systems

August 22, 2018 — Philips recently announced the introduction of the Epiq CVx cardiovascular ultrasound system. Built on the Epiq ultrasound platform, Epiq CVx is specifically designed to increase diagnostic confidence and simplify workflow for clinicians, giving them more time to interact with their patients and reducing the need for repeat scans. According to Philips, 95 percent of a group of clinicians who were shown the new system believed it offered improved image quality: sharper and clearer images [1]. Philips is also introducing the Epiq CVxi, specifically tailored for use in the interventional lab. Both systems are CE marked and have received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

“The EPIQ CVx brings together advanced image quality, quantification and intelligence specifically for the cardiologist,” said Roberto Lang, M.D., professor of medicine, director, Noninvasive Cardiac Imaging Laboratory at the University of Chicago Medicine. “I was impressed with the TrueVue feature, which elevates 3-D ultrasound imaging to a totally new level and could impact diagnostic ability of echocardiography in different clinical scenarios, like better understanding of the anatomy of mitral valves.”

As pressures on healthcare systems around the world continue to increase, cardiologists have more patients to examine in less time, according to Philips. By using advanced 3-D organ modeling, image slicing and proven quantification, the company said its anatomical intelligence is helping make ultrasound exams easier to perform and more reproducible.

Philips described the Epiq CVxi as a third-generation integrated ultrasound-angiography cath lab solution for real-time, workflow-optimized image guidance and advanced quantification for structural heart procedures.

Debuting at the European Society of Cardiology (ESC) 2018 annual meeting, Aug. 25-29 in Munich, Germany, the Epiq CVx includes higher processing power, exceptional image clarity and sharpness, improved exam efficiencies, and more robust and reproducible quantification, enabled by anatomical intelligence. The system includes TrueVue, giving clinicians the ability to see photorealistic renderings of the heart, which improves cardiac anatomy analysis by offering detailed tissue and depth perception imaging through a new virtual light source. It provides cardiologists with high image quality through the latest generation OLED monitor, offering a more dynamic, wider viewing angle for side-by-side image comparison.

The system offers a variety of new features including Dynamic Heart Model. Building on Philips HeartModelA.I., it uses anatomical intelligence to automatically quantify left ventricle function to produce a multi-beat analysis for adult patients. Dynamic Heart Model has been shown to reduce the amount of time to generate a 3-D ejection fraction, an important measurement in determining how well the heart is pumping out blood, by 83 percent [2]. It also delivers a high level of robustness and reproducibility, even for patients with an arrhythmia. The systems also includes the new S9-2 PureWave Transducer, which simplifies pediatric cardiac imaging exams by displaying high levels of detail and contrast resolution through the single-crystal technology. It also provides tissue information at greater depths and enhances pediatric capability for coronary artery visualization.

The Epiq CVx includes a cardiology-specific user interface that simplifies the exam experience through a user-configurable touch-screen interface, allowing clinicians to personalize their controls and improve workflow for their cardiology exams. The system features strong security capabilities and protocols.

The Epiq CVxi with EchoNavigator, designed specifically for use in the cath lab, is Philips’ third-generation interventional solution to streamline communication between the interventional cardiologist and the echocardiographer during complex interventional exams. Combining live ultrasound and X-ray information into one intuitive view, EchoNavigator helps interventional cardiologists oversee procedures along with the location of key anatomical structures. In addition, MultiVue provides more flexibility when using 3-D during diagnostic or interventional procedures as the clinician can see multiple and flexible views at once.

For more information: www.usa.philips.com/healthcare

 

References

[1] Results obtained during user demonstrations performed in December 2017 with the Epiq CVx and the iE33 systems. The research was designed and supervised by Use-Lab GmbH, an independent and objective engineering consultancy and user interface design company. The tests involved 42 clinicians from 17 countries. The various types of cardiac customer segments represented were adult diagnostics and interventional, adult diagnostics, and pediatric diagnostics and interventional.

[2] Prado A, Narang A, Volpato V, Kumari N, Prater D, Addetia K, Patel AR, Mor-Avi V, Lang RM: Automated dynamic measurement of left heart chamber volumes for quantification of ejection and filling parameters. JASE 31(6):B111; 2018

 

Related Content

An example of cardiac ultrasound longitudinal strain measurements on the Epsilon EchoInsight software. This can be used to assess cardiotoxicity from chemotherapy agents. 

An example of cardiac ultrasound longitudinal strain measurements on the Epsilon EchoInsight software. This can be used to assess cardiotoxicity from chemotherapy agents. 

News | Cardio-oncology | February 25, 2021
February 25, 2020 — Results of a multi-centre, international, clinical trial co-led by Peter Munk Cardiac Centre (PMC
icobrain cva allows the quantitative assessment of tissue perfusion by reporting the volume of core and perfusion lesion by quantifying Tmax abnormality and CBF abnormality together with the mismatch volume and ratio
News | Artificial Intelligence | February 23, 2021
February 23, 2021 — icometrix, world leader in imaging...
GE Healthcare introduced its artificial intelligence (AI) automation features on its Voluson Swift ultrasound platform at the 2020 Radiological Society of North America (RSNA) virtual meeting. Features of this system include semi-automated contouring, auto identification of fetal anatomy and positioning on imaging. AI is seeing increasing integration in ultrasound systems from numerous vendors.

GE Healthcare introduced its artificial intelligence (AI) automation features on its Voluson Swift ultrasound platform at the 2020 Radiological Society of North America (RSNA) virtual meeting. Features of this system include semi-automated contouring, auto identification of fetal anatomy and positioning on imaging. AI is seeing increasing integration in ultrasound systems from numerous vendors.

Feature | Ultrasound Imaging | February 18, 2021 | By Dave Fornell, Editor
Recent advances in ultrasound image sy...
Insightec plans to expand in Latin America through a partnership with Strattner
News | Focused Ultrasound Therapy | February 16, 2021
February 16, 2021 — Insightec, a global healthcare company focused on creating the next generation of patient care, a
Brazilian researchers found that the higher the lung ultrasound score the greater the risk of ICU admission, intubation and death. Image courtesy of Julio Alencar

Brazilian researchers found that the higher the lung ultrasound score the greater the risk of ICU admission, intubation and death. Image courtesy of Julio Alencar

News | Coronavirus (COVID-19) | February 11, 2021
February 11, 2021 — ...

Images in 69-year-old man with biopsy-confirmed Gleason score 7 (3+4) prostate cancer. (a) Pretreatment axial T2-weighted fast spin-echo MRI scan (repetition time msec/echo time msec, 3820/97) shows tumor in midline anterior transition zone (arrow). (b) Intraoperative MRI scan shows contoured rectal wall (red line), prostate margin (blue outline), and region of interest (orange outline). Because the urethra was included in planned treatment volume, a suprapubic catheter was placed for continuous bladder drainage during treatment. (c) Intraoperative MRI scan shows focused ultrasound beam path (blue) overlaid on treatment plan. Rectangles illustrate each sonication spot. (d) Thermal map image obtained during treatment with heat deposition color coded in red overlaid on sonication spot. (e) Axial gadopentetate dimeglumine-enhanced MRI scan (230/2.97) obtained immediately after treatment shows devascularized ablated volume (arrows). (f) Corresponding T2-weighted fast spin-echo MRI scan (3820/97) at 5 months after ablation shows complete involution of transition zone. All seven cores from treatment area margins were negative for cancer at biopsy. Image courtesy of the Radiological Society of North America

News | Prostate Cancer | February 05, 2021
February 5, 2021 — A technique that delivers...
New technology introduces a new level of realism to pediatric emergency training

PRNewsfoto/Gaumard Scientific

News | Pediatric Imaging | January 28, 2021
January 28, 2021 — Gaumard Scientific Co., a healthcare simula